OSTX Similar Chart Price Prediction
The price of OSTX is predicted to go up -5.59%, based on the high correlation periods with IBRX. The similarity of these two price pattern on the periods is 96.84%.
OSTX
IBRX
Down: -5.59%Similarity: 96.84%
OSTX Revenue Forecast
OSTX EPS Forecast
OSTX FAQs
What is bull’s view on OSTX?
What is bear's view on OSTX?
OSTX Analyst's Forecast
Jason McCarthy
Maxim Group
Strong Buy
Price Target
$8 → $15
Upside
+264.08%
Maxim analyst Jason McCarthy raised the firm's price target on OS Therapies to $15 from $8 and keeps a Buy rating on the shares. The firm cites the company's positive Phase 2b top-line data for OST-HER2 in recurrent osteosarcoma, meeting the primary endpoint of 12-month event free survival. The data now positions the company to meet with the FDA by the end of Q1 to discuss the potential for filing for accelerated approval, which would include comparison to a synthetic control already requested by the FDA and which OS Therapies has already started building, the analyst tells investors in a research note.
Jason McCarthy
Maxim Group
Strong Buy
Price Target
$8
Upside
+300%